Table 1.
Baseline characteristics of the study populations
| A1C ≥7.0% cohort |
A1C <7.0% cohort |
|||
|---|---|---|---|---|
| Control | CGM | Control | CGM | |
| n | 46 | 52 | 63 | 67 |
| Female sex | 26 (57) | 31 (60) | 33 (52) | 36 (54) |
| Age (years) | 44.69 ± 12.35 | 41.23 ± 11.21 | 31.84 ± 17.63 | 29.38 ± 16.29 |
| Non-Hispanic white race | 42 (91) | 52 (100) | 61 (97) | 64 (96) |
| Duration of diabetes (years) | 21.83 ± 10 | 23.57 ± 11 | 18.15 ± 15 | 16.28 ± 15 |
| Daily insulin dose (units) | 45.97 ± 24 | 43.20 ± 19 | 42.23 ± 17 | 39.72 ± 13 |
| Pump users | 39 (85) | 43 (83) | 50 (79) | 62 (93) |
| A1C at baseline (%) | 7.61 ± 0.50 | 7.61 ± 0.49 | 6.50 ± 0.34 | 6.39 ± 0.49 |
| Daily home glucose meter reading (times/day) | 6.19 ± 1.94 | 6.89 ± 3.17 | 6.31 ± 2.72 | 7.67 ± 3.07 |
Data are means ± SD or n (%). A1C ≥7.0% cohort is only for those aged ≥25 years. The only statistical difference between control and CGM patients was in the proportion of pump users among the A1C <7.0% cohort (P = 0.03).